Precigen Stock Up 280% in a Year — Is FDA Approval Behind This Big New Investor Bet?

On November 14, San Diego-based Tang Capital Management disclosed a new position in Precigen (NASDAQ:PGEN), adding approximately $40.8 million, or 12.4 million shares, per SEC filings.According to a filing with the U.S. Securities and Exchange Commission dated November 14, Tang Capital Management established a new position in Precigen (NASDAQ:PGEN), acquiring 12.4 million shares valued at about $40.8 million as of September 30. This new holding accounts for 1.6% of the fund’s approximately $2.6 billion in reportable U.S. equity assets.Top five fund holdings after the filing:  Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool